Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy and Safety of Beta-blockers Drugs in Adults With Spinal Hemangioma: a Prospective Cohort Study

NCT05106179 is registered in ClinicalTrials.gov with Center for Vascular Pathology, Moscow as lead sponsor.

NCT NCT05106179
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05106179 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy and Safety of Beta-blockers Drugs in Adults With Spinal Hemangioma: a Prospective Cohort Study
Lead sponsor
Center for Vascular Pathology, Moscow
Phase
Phase 4
Overall status
Unknown status
Start date
December 31, 2021
Completion date
December 31, 2023
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

beta blocker toxicity, spinal hemangioma, spinal tumor